Survey on patient preferences for myeloma treatment - Myeloma

Por um escritor misterioso
Last updated 10 novembro 2024
Survey on patient preferences for myeloma treatment - Myeloma
  Dutch (Nederlands)  Voorkeuren van patiënten omtrent behandelingen voor myeloom Finnish (suomi) Potilaan mieltymykset myelooman hoidoista French (français) Préférences des patients concernant les traitements du myélome German (Deutsch) Patientenpräferenzen zu Myelombehandlungen Romanian (Română) Preferințele pacientului cu privire la tratamentele pentru mielom Spanish (Español) Preferencias del paciente sobre los tratamientos del mieloma     Our work is driven by the needs of myeloma patients. To best represent the patient voice in policy decisions, we need to…
Survey on patient preferences for myeloma treatment - Myeloma
Multiple Myeloma Hub on X: Clinician preferences on the treatment of smoldering multiple myeloma, check out our key points below! 🎙️ What treatment would you recommend for smoldering #multiplemyeloma? HCPs, share your
Survey on patient preferences for myeloma treatment - Myeloma
Cancers, Free Full-Text
Survey on patient preferences for myeloma treatment - Myeloma
Trends in overall survival and costs of multiple myeloma, 2000–2014
Survey on patient preferences for myeloma treatment - Myeloma
Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment
Survey on patient preferences for myeloma treatment - Myeloma
Multiple Myeloma Treatments
Survey on patient preferences for myeloma treatment - Myeloma
Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study - ScienceDirect
Survey on patient preferences for myeloma treatment - Myeloma
Patient Confidence and Information Preferences During the Treatment Decision-making Process: Results From a Large Multiple Myeloma Patient Survey Across 12 Countries in Europe and Israel - ScienceDirect
Survey on patient preferences for myeloma treatment - Myeloma
Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment options - ScienceDirect
Survey on patient preferences for myeloma treatment - Myeloma
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study - The Lancet Oncology

© 2014-2024 citytv24.com. All rights reserved.